The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hyaluronidase synthase 3 (HAS3) variant and anthracycline-related cardiomyopathy: A report from the Children’s Oncology Group.
Can-Lan Sun
No relevant relationships to disclose
Xuexia Wang
No relevant relationships to disclose
Wei Liu
No relevant relationships to disclose
Saro Armenian
No relevant relationships to disclose
Hakon Hankonarson
No relevant relationships to disclose
Lindsey Hageman
No relevant relationships to disclose
Yan Ding
No relevant relationships to disclose
Wendy Landier
No relevant relationships to disclose
Frank G. Keller
No relevant relationships to disclose
Joseph Philip Neglia
No relevant relationships to disclose
Sunil J. Desai
No relevant relationships to disclose
Charles A. Sklar
No relevant relationships to disclose
Sharon M. Castellino
No relevant relationships to disclose
Irene Cherrick
No relevant relationships to disclose
Zoann Dreyer
No relevant relationships to disclose
Yutaka Yasui
No relevant relationships to disclose
Mary V. Relling
No relevant relationships to disclose
Smita Bhatia
No relevant relationships to disclose